UTI MNC Growth Direct Plan
SIP amount
Min. ₹500
Lumpsum amount
Min. ₹5,000

UTI MNC Growth Direct Plan

NAV
₹399.7149
-0.50%
(9 May)
AUM
2,640 Cr
TER
1.17%
Risk
Very High Risk
Rating
Insights
Net Asset Value (NAV) is below its 200 days moving average
Asset Under Management (AUM) is in the top 25% of comparable funds
Total Expense Ratio (TER) is in the top 25% of comparable funds
In beta. Send feedback here.
Compare with other fund
1Y
+11.2%
+4.0%
+2.5%
+2.0%
+0.9%
3Y
+33.6%
+31.6%
+32.4%
+14.1%
+32.9%
5Y
+33.7%
+37.3%
+31.5%
+16.8%
+33.1%
ALL
+17.9%
+12.6%
+16.6%
+14.6%
+11.7%
VOL
16.4%
21.3%
19.9%
13.2%
20.4%
TER
0.6%
1.0%
0.9%
1.2%
0.8%
AUM
₹6,047 Cr
₹2,329 Cr
₹1,281 Cr
₹2,640 Cr
₹5,035 Cr
INFO
1.09
0.59
0.84
1.10
0.57
Past performance
Past performance is no guarantee of future returns.
Had you invested
Over the last
1Y
3Y
ALL
Your returns would have been
UTI MNC (G)
₹1,00,00,00,000
14.0%
Fixed deposit
₹40,00,00,000
6.0%
Bank savings
₹40,00,00,000
3.0%
See fund holdings as of 30th Apr
Top holdings
Maruti Suzuki India Ltd
10.0%
Nestle India Ltd
5.7%
United Spirits Ltd
4.6%
Procter & Gamble Health Ltd
4.6%
Vedanta Ltd
4.0%
Hindustan Unilever Ltd
3.8%
Net Current Assets
3.8%
Britannia Industries Ltd
3.4%
3M India Ltd
3.1%
Procter & Gamble Hygiene and Health Care Ltd
2.8%
Top industry exposure
Consumer Defensive
22.9%
Consumer Cyclical
22.3%
Healthcare
13.9%
Industrials
13.1%
Technology
9.9%
Other information
Minimum SIP
₹500
Minimum lumpsum
₹5,000
Additional lumpsum
₹1,000
Portfolio turnover
35%
Lock-in period
-
Exit load
• 1% for redemption within 365 days
Fund objective
The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of multinational companies. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.
Fund manager(s)
Karthikraj Lakshmanan

FAQs